5 August 2021 - Newsletter

Experienced and well-connected: Dr Alan Levy becomes Chairman of the Board of Salvia BioElectronics

With the appointment of Dr. Alan Levy as Chairman of the Board, the Dutch growth company Salvia BioElectronics brings profound life science expertise and decades of experience to the team. Dr Levy has successfully exited four out of five early-stage healthcare companies and also sits on the board of Intuitive Surgical. Salvia develops electromedical neurostimulation solutions for the treatment of chronic migraine and has been in the portfolio of SHS since autumn 2021, which is represented on the Salvia Board of Directors by Manfred Ulmer-Weber. Salvia recently received the US Breakthrough Device Designation. As Chairman, Dr. Levy has set himself the goal of decisively improving the situation of migraine patients worldwide with Salvia.

More information: t1p.de